aarjmd - Asian Academic Research
Transcription
aarjmd - Asian Academic Research
AARJMD VOLUME 3 ISSUE 12 (DECEMBER 2016) ISSN : 2319 - 2801 A Peer Reviewed International Journal of Asian Academic Research Associates AARJMD ASIAN ACADEMIC RESEARCH JOURNAL OF MULTIDISCIPLINARY TOBACCO AND ALCOHOL CONSUMPTION ANTICIPATING THE PRESENCE OF THE METABOLIC DISORDER SIHEM. SOUISSI1; FETHI. BEN SLAMA2; ASMA. AYED3; HABIB. ASKRI4; NABIL. GUERMAZI5; OMRANE. BEL HADJ6 1 University Tunis El Manor, Faculty of Science of Tunis, Laboratory of Biochemistry & Techno biology. 2 National Institute of Public Health. Tunis. Tunisia 3 Expertise Centre for Aviation Medicine of Tunis. Tunisia 4 Expertise Centre for Aviation Medicine of Tunis. Tunisia 5 Expertise Centre for Aviation Medicine of Tunis. Tunisia 6 University Tunis El Manor, Faculty of Science of Tunis, Laboratory of Biochemistry & Techno biology. Abstract Objective: To evaluate the effect of tobacco and alcohol consumption on the development of obesity and metabolic syndrome (MS). Methods: The study was conducted on three groups which are selected according to the criteria of the MS defined by the IDF and by the BMI. P1: with MS only P2: with MS and obesity P3: obese only Results: The three populations have a visceral obesity, with a significant difference. P2 consume a quantity of alcohol in percentage strictly exceeding 210 g/ week than P1 and P3, (p=0.12). P1 consume in percentage of frequency of alcohol more than in P2 and P3, (p=0.3). But the regular rate is more important for the P3 than the P1 or P2, (p=0.07). The difference is not significant between the three populations in the number of packages of tobacco smoked per year, even if P3 smoke in the number of packages of tobacco/ year less than P1 and P2. Conclusion: The alcohol consumption appears to increase visceral obesity. The occasional consumption with a very large amount at once and with a bad snacking is not fattening but can lead to MS. But a regular consumption of alcohol, with a quantity less than 30 g/day, can produce obesity without MS. Key words: Obesity; Metabolic syndrome; tobacco; alcohol; healthy lifestyle. Asian Academic Research Journal of Multidisciplinary www.asianacademicresearch.org AARJMD VOLUME 3 ISSUE 12 (DECEMBER 2016) ISSN : 2319 - 2801 References 1- Balkau, B., Deanfield, J., Després, J P., Bassand, J P., Fox, K K A., and Smith, S C. (2007), ―International Day for the Evaluation of Abdominal Obesity (IDEA), A Study of Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in 168 000 Primary Care Patients in 63 Countries‖. Circulation, American Heart Association. 116 (17), pp.19421951. 2- OMS. (2000). Obésité : prévention et prise en charge de l'épidémie mondiale. Rapport d’une Consultation de l’OMS 2000.Organisation mondiale de la Santé, Genève. pp 1-300. 3- Beck, E., Esser, N., Paquot, N., and Scheen, A J. (2009). Sujets de poids normal «métaboliquement obèses» et sujets obèses «métaboliquement sains». Rev Med Suisse, pp. 1644-1649 4- Ruderman, N., Chisholm, D., Pi-Sunyer, X., and Schneider, S. (1998). The metabolically obese, normal-weight individual revisited. Diabetes. 47, pp. 699-713. 5- Sims, E A. (2001). Are there persons who are obese, but metabolically healthy? Metabolism. 50, pp. 1499-1504. 6- Esser, N., Paquot, N., Scheen, A J. (2009). Sujets «métaboliquement sains», bien qu’obèses. 1re partie : Diagnostic, physiopathologie et prévalence. Obésité. 4, pp. 56-65. 7- Beck, N., Scheen, A J. (2009). Sujets «métaboliquement obèses » sans excès de poids : un phénotype interpellant. Rev Med Liège. 64, pp14-22. 8- Beck, E., Paquot, N., and Scheen A J. (2008). Sujets «métaboliquement obèses» de poids normal. 1re partie : Diagnostic, physiopathologie et prévalence. Obésité. 3, pp. 184-93. 9- Esser, N., Scheen, A J. (2009). Sujets obèses sans anomalies métaboliques. Rev Med Liège. 64, pp.148-157. 10- Azizi, F., Salehi, P., Etemadi, A., and Zahedi A S. (2003). Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 61, pp. 29-37. 11- Cameron, A J., Magliano, D J., Zimmet, P Z., Welborn, T., and Shaw, J E. (2007). The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res. Clin. Pract. 77(3), pp. 471-478. 12- Balkau, B., Vernay, M., Mhamdi, L., Novak, M., Arondel, D., and Vol, S. (2003). The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab. 29(5), pp. 526-532. 13- SFA. (2001). Recommandations pour la pratique clinique, Alcoologie et Addictologie. La Société Française d'Alcoologie. 23 (Suppl 4), pp. 1S-76S. 14- Kiritze-Topor, P. (2008). Conduites d’alcoolisation: du risque à la dépendance- Repérage et intervention brève en médecine générale. John libbey.Eurotext. 4(1), pp. 26-32. 15- Rehm , J., Monteiro, M. (2005). Alcohol consumption and burden of disease in the Americas: implications for alcohol policy. Rev Panam Salud Publica. 18(4/5), pp. 241–8. 16- Shaper, A G., Ashby, D., and Pocock, S J. (1988). Blood pressure and hypertension in middle-aged British men. J Hypertens. 6, pp. 367-374. 17- Amy, Z., Russell, F M., Dorn, J., Jo, L., Freudenheim., and Nochajski, T. (2006). Lifetime Alcohol Drinking Pattern is Related to the Prevalence of Metabolic Syndrome. The Asian Academic Research Journal of Multidisciplinary www.asianacademicresearch.org AARJMD VOLUME 3 ISSUE 12 (DECEMBER 2016) ISSN : 2319 - 2801 Western New York Health Study (WNYHS). European Journal of Epidemiology. 21(2), pp. 129-138. 18- Kenneth, J., Mukamal, M D., M P H, M A., and Rimm, E B. (2001). Alcohol’s Effects on the Risk for Coronary Heart Disease. Harvard Medical School, Boston, Massachusett. 25(4), pp. 255-261. 19- Carreau J. Consommation d’alcool (Résumé), Musset S. Institut National de la Santé et de la Recherche Médicale, France, pp. 1-13. 20- Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., Patra, J. (2009). Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. The Lancet. 373 (9682), pp. 2223–2233. 21- Anderson, P., Gual, A., Colom, J. (2005). Alcohol and Primary Health Care: Clinical Guidelines on Identification and Brief Interventions. Department of Health of the Government of Catalonia. Barcelona, pp. 1-172. 22- WHO (2004). Global Status Report on Alcohol. World Health Organization, Geneva, pp. 1-94. 23Casset, M. Addictions 5. Données épidémiologiques, pp. 1-6. http://www.lecomprime.com/cours/files/2013/09/Addictions-chap-5-epidemio.pdf (consulted 10/05/15). 24- SFA. Société Française d’Alcoologie. (2015). Mésusage de l’alcool, dépistage, diagnostic et traitement (Recommandation de bonne pratique). Alcoologie et Addictologie. 37 (1), pp. 584. 25- Regula Thut Borner. (2007). L’alcool, une bombe calorique. LE MENU 6l2007, pp. 6869. 26- Breslow, R A., Chiung , C M,. Graubard, B I., Jacobovits, T., and Ashima K Kant (2013). Diets of drinkers on drinking and nondrinking days: NHANES 2003–2008. Am J Clin Nutr. 97 (5), pp. 1068-1075. 27- Wannamethee, S G., Shaper, A G. (2003). Alcohol, body weight, and weight gain in middle-aged men. American Journal Clinical Nutrition. 77, pp.1312-1317. 28- Klatsky et al. (1996). Alcohol and hypertension. Clin Chim Acta. 246, pp. 91-105. 29- Taskinen, M R., Nikkilä, E A., Valimäki, M., Sanet, T., and Kuusit, T. (1987). Alcoholinduced changes in serum lipoproteins and in their metabolism. Am Heart J. 113, pp. 458264. 30- Toumbourow, JW., Williamas, I R., White, V M., Snow, P C., Munro, G D., and Schofield, P E. (2004). Predition of alcohol-related harm from controlled drinking strategies and alcohol consumption trajectories. Addiction. 99, pp. 498-508. 31- U.S. Department of Health and Human Services . (2014). The Health consequences of Asian Academic Research Journal of Multidisciplinary www.asianacademicresearch.org AARJMD VOLUME 3 ISSUE 12 (DECEMBER 2016) ISSN : 2319 - 2801 smoking—50 Years of Progress. A report of the surgeon général. Washington (DC), pp. 11081. 32- Smith, U. (1995). Smoking elicits the insulin resistance syndrome: new aspects of the harmful effect of smoking. J Intern Med. 237, pp. 435-437. 33- Comité Française d’Education pour la Santé CFES (1999). La Santé en Chiffres (Tabac), Education pour la santé pour mieux vivre, pp. 1-10. 34- Ben Romdhane H. (2007). Enquête Nationale Santé 2005-2006. Projet TAHINA- INSPAL, pp. 1-304. 35- Le Quotidien-Tunisie to day. (2014). Le tunisien dépense plus pour le tabac que pour sa santé. Actualités de la Tunisie. http://www.tunisia-today.com/archives/11823 (consulted 04/11/14) 36- Weitzman, M., Cook, S., Auinger, P., Florin, T A., Daniels,S., Nguyen, M., Winickoff, J P. (2005). Tobacco Smoke Exposure Is Associated With the Metabolic Syndrome in Adolescents. American Heart Association. Circulation.112, pp. 862-869. 37- Bjartveit, K.., Tverdal, A. (2005). Health consequences of smoking 1-4 cigarettes per day. Tobacco Control. Vol. 14 (5), pp. 315-320. 38- Peto R (1986). Influence of dose and duration of smoking on lung cancer rates. IARC Sci Publ; (74):23-33. 39- Mahmud A, Feely J. (2003). Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension. 41(1), pp. 183-187. 40- Inpes. (2015). Les risques du tabagisme et les bénéfices de l’arrêt/ Les solutions pour arrêter de fumer. Dépliant Inpes, réf. 220-17012-de « J’arrête de fumer, des méthodes pour y parvenir ». Guide pratique Inpes, réf. 220-90411-B, France, pp. 1-2. Asian Academic Research Journal of Multidisciplinary www.asianacademicresearch.org